Oxford University first tested the Covid-19 vaccine response in children
Oxford University has launched a research program aimed at the first time assessing the safety and immune response of the Covid-19 vaccine in children.
|Patient samples Covid-19 was stored at a laboratory in the coastal city of West Palm Beach, USA in March 2020. Photo: AFP|
According to the latest announcement from the University of Oxford, the new midterm testing will determine whether the Covid-19 resistant vaccine, which it jointly developed with the pharmaceutical company AstraZeneca, is effective in people aged 6-17 years. .
Oxford University says about 300 volunteers will sign up for the pilot program and it is expected that volunteers will be vaccinated this month.
The two-dose Oxford / AstraZeneca vaccine was recently hailed as the “world vaccine” for being cheaper and easier to distribute than some other vaccines.
Pharmaceutical firm AstraZeneca has reached its goal of producing 3 billion doses of the Oxford / AstraZeneca vaccine this year and is expected to have more than 200 million doses per month in April.
Since the outbreak of Covid-19 in late 2019, the world has recorded more than 107 million infected people and 2.36 million deaths from the virus, according to data from Johns Hopkins University.
However, more and more doctors and health officials warn that, even with the introduction of a series of safe and effective vaccines, Covid-19 could be permanent, endemic and flare up. season.